RL
75
2
SJM
19
2
NWSA
71
2
WEC
39
3
VIX
25
-18
DHI
27
-9
TRIP
64
4
KMX
54
-10
C
51
3
EQIX
57
-2
HSIC
44
2
FRT
36
2
LMT
39
10
ADI
57
2
LLY
45
8
MAC
51
-2
VLO
26
3
KLAC
56
11
XEL
51
3
BLK
50
3
RL
75
2
SJM
19
2
NWSA
71
2
WEC
39
3
VIX
25
-18
DHI
27
-9
TRIP
64
4
KMX
54
-10
C
51
3
EQIX
57
-2
HSIC
44
2
FRT
36
2
LMT
39
10
ADI
57
2
LLY
45
8
MAC
51
-2
VLO
26
3
KLAC
56
11
XEL
51
3
BLK
50
3
Financhill
Back

Kymera Therapeutics Stock Price Chart

FREE REPORT: 2025 Gold Price Outlook

Get Your Copy of "2025 Gold Forecast: A Perfect Storm for Demand" Here.
Sell
39

KYMR
Kymera Therapeutics

Last Price:
$40.93
Seasonality Move:
2.79%

7 Day Trial

ALL ACCESS PASS

$ 7

Elon Musk Predicts MAJOR Crisis in Trump's First Year

See Why Investors are Pouring Mountains of Cash into Certain Companies Trump Wants to Solve the Problem.
  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and KYMR is experiencing buying pressure, which is a positive indicator for future bullish movement.

Kymera Therapeutics Price Chart Indicators

Moving Averages Level Buy or Sell
8-day SMA: 41.15 Sell
20-day SMA: 44.05 Sell
50-day SMA: 45.84 Sell
200-day SMA: 41.3 Sell
8-day EMA: 41.35 Sell
20-day EMA: 43.14 Sell
50-day EMA: 44.71 Sell
200-day EMA: 41.09 Sell

Kymera Therapeutics Technical Analysis Indicators

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.61 Sell
Relative Strength Index (14 RSI): 40.6 Sell
Chaikin Money Flow: 196490 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (41.49 - 46.41) Sell
Bollinger Bands (100): (42.83 - 48.77) Sell

Kymera Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Technical Analysis for Kymera Therapeutics Stock

Is Kymera Therapeutics Stock a Buy?

KYMR Technical Analysis vs Fundamental Analysis

Sell
39
Kymera Therapeutics (KYMR) is a Sell

Is Kymera Therapeutics a Buy or a Sell?

Kymera Therapeutics Stock Info

Market Cap:
2.6B
Price in USD:
40.79
Share Volume:
219.2K

Kymera Therapeutics 52-Week Range

52-Week High:
53.27
52-Week Low:
22.35
Sell
39
Kymera Therapeutics (KYMR) is a Sell

Kymera Therapeutics Share Price Forecast

Is Kymera Therapeutics Stock a Buy?

  • Kymera Therapeutics share price is 40.79 while KYMR 8-day exponential moving average is 41.35, which is a Sell signal.
  • The stock price of KYMR is 40.79 while Kymera Therapeutics 20-day EMA is 43.14, which makes it a Sell.
  • Kymera Therapeutics 50-day exponential moving average is 44.71 while KYMR share price is 40.79, making it a Sell technically.
  • KYMR stock price is 40.79 and Kymera Therapeutics 200-day simple moving average is 41.09, creating a Sell signal.

Fundamental Analysis of Kymera Therapeutics

Is Kymera Therapeutics a good investment?

  • Analysts estimate an earnings decrease this quarter of $0.03 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.12 per share, and a decrease next year of $0.37 per share.

Technical Analysis of Kymera Therapeutics

Should I short Kymera Therapeutics stock?

* Kymera Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.